ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for discussion Cadastre-se para interagir em nossos fóruns de ativos e discutir com investidores ideias semelhantes.

ATXI Avenue Therapeutics Inc

0,1499
-0,0027 (-1,77%)
Pré-mercado
Última atualização: 10:14:36
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Avenue Therapeutics Inc ATXI NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0027 -1,77% 0,1499 10:14:36
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,1526
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/03/202409:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
18/03/202417:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/03/202409:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/03/202409:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
22/02/202410:30GLOBEAvenue Therapeutics Announces Publication in Drug..
11/01/202410:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
05/01/202411:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
04/01/202410:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
02/01/202410:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
01/12/202310:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
13/11/202318:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
02/11/202316:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
31/10/202310:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
05/09/202309:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
14/08/202317:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
10/08/202317:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/08/202309:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/07/202309:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/07/202309:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
15/05/202317:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..
12/05/202309:30GLOBEAvenue Therapeutics Reports First Quarter 2023 Financial..
27/04/202309:30GLOBEAvenue Therapeutics to Present at Aegis Capital Virtual..
17/04/202317:01GLOBEAvenue Therapeutics Announces Regulatory Update Based on..
30/03/202317:10GLOBEFortress Biotech Reports Record 2022 Financial Results and..
30/03/202317:01GLOBEAvenue Therapeutics Reports Full Year 2022 Financial Results..

Seu Histórico Recente

Delayed Upgrade Clock